| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +2,282,602 | 100% | $1.31 | +$2,997,466 |
| Sells | 0 | ||||
| Net | +4 | +2,282,602 | 100% | +$2,997,466 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sergio Traversa | Chief Executive Officer, Director | $5,356,000 | +$1,065,608 | +25% | 12 Dec 2025 |
| Maged Shenouda | Chief Financial Officer | $3,296,000 | +$1,245,268 | +61% | 12 Dec 2025 |
| Paul Kelly | COO, Director | $1,105,049 | +$284,060 | +35% | 12 Dec 2025 |
| Chuck Ence | CA and CO | $888,648 | +$402,530 | +83% | 12 Dec 2025 |
| Cedric O'Gorman | Chief Medical Officer | $32,185 | 23 May 2023 | ||
| ERIC THOMAS SCHMIDT | Director | 25 May 2023 | |||
| CHARLES J. CASAMENTO | Director | 12 Dec 2025 | |||
| Fabiana Fedeli | Director | 12 Dec 2025 | |||
| John Glasspool | Director | 12 Dec 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|